Skip to content
Disclosery

DCVC Opportunity Fund II GP, LLC

Follow

13F filer, CIK 1668343, PALO ALTO, CA

DCVC Opportunity Fund II GP, LLC reported $16,587,374 across 2 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-26-015687

Period
2025-12-31
Reported value
$16.6M
Holdings
2
Top 10 weight
100%
New
1
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
IONQnew+9,521$427K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001104659-26-015687, largest first. % of portfolio is the value over $16,587,374, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,951,141 shares; 2024Q4: 3,951,141 shares; 2025Q1: 3,951,141 shares; 2025Q2: 3,951,141 shares; 2025Q3: 3,951,141 shares; 2025Q4: 3,951,141 shares 3,951,141$16.2M97.42%0Timeline
IONQIONQ INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 9,521 shares 9,521$427K2.58%newTimeline

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-015687 base2026-02-17acceptance time not in the bulk data set